Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Invasive Breast Cancer|Ductal Carcinoma in Situ
Interventions: DRUG: Mifepristone
Sponsor: University of California, San Diego